AMP

The authors of CAP's practical framework for NGS testing of inherited disorders see it as a baseline for future efforts to standardize NGS testing.

At a Thermo Fisher-sponsored workshop, two companies argued for the clinical utility of PGx LDTs as FDA prepared to issue a warning against unapproved tests.

Researchers separately found that the assay had high concordance with other techniques in cancers including colorectal and endometrial carcinomas.

Company officials stressed the firm's drive to help connect industry and academia, and expand access to tools for precision medicine.

Seventeen organizations don't support the Diagnostic Accuracy and Innovation Act as written and would like lawmakers to advance a CLIA-centric framework.